450 related articles for article (PubMed ID: 15280393)
21. Binding of elongin A or a von Hippel-Lindau peptide stabilizes the structure of yeast elongin C.
Botuyan MV; Koth CM; Mer G; Chakrabartty A; Conaway JW; Conaway RC; Edwards AM; Arrowsmith CH; Chazin WJ
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9033-8. PubMed ID: 10430890
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1-F-box interface.
Gorelik M; Orlicky S; Sartori MA; Tang X; Marcon E; Kurinov I; Greenblatt JF; Tyers M; Moffat J; Sicheri F; Sidhu SS
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3527-32. PubMed ID: 26976582
[TBL] [Abstract][Full Text] [Related]
23. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.
Stebbins CE; Kaelin WG; Pavletich NP
Science; 1999 Apr; 284(5413):455-61. PubMed ID: 10205047
[TBL] [Abstract][Full Text] [Related]
24. Solution structure and dynamics of yeast elongin C in complex with a von Hippel-Lindau peptide.
Botuyan MV; Mer G; Yi GS; Koth CM; Case DA; Edwards AM; Chazin WJ; Arrowsmith CH
J Mol Biol; 2001 Sep; 312(1):177-86. PubMed ID: 11545595
[TBL] [Abstract][Full Text] [Related]
25. Structure-Guided Design of Peptides as Tools to Probe the Protein-Protein Interaction between Cullin-2 and Elongin BC Substrate Adaptor in Cullin RING E3 Ubiquitin Ligases.
Cardote TAF; Ciulli A
ChemMedChem; 2017 Sep; 12(18):1491-1496. PubMed ID: 28776949
[TBL] [Abstract][Full Text] [Related]
26. Structure of a glomulin-RBX1-CUL1 complex: inhibition of a RING E3 ligase through masking of its E2-binding surface.
Duda DM; Olszewski JL; Tron AE; Hammel M; Lambert LJ; Waddell MB; Mittag T; DeCaprio JA; Schulman BA
Mol Cell; 2012 Aug; 47(3):371-82. PubMed ID: 22748924
[TBL] [Abstract][Full Text] [Related]
27. Selective recruitment of an E2~ubiquitin complex by an E3 ubiquitin ligase.
Spratt DE; Wu K; Kovacev J; Pan ZQ; Shaw GS
J Biol Chem; 2012 May; 287(21):17374-17385. PubMed ID: 22433864
[TBL] [Abstract][Full Text] [Related]
28. Insights into Cullin-RING E3 ubiquitin ligase recruitment: structure of the VHL-EloBC-Cul2 complex.
Nguyen HC; Yang H; Fribourgh JL; Wolfe LS; Xiong Y
Structure; 2015 Mar; 23(3):441-449. PubMed ID: 25661653
[TBL] [Abstract][Full Text] [Related]
29. HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases.
Paltoglou S; Roberts BJ
Oncogene; 2007 Jan; 26(4):604-9. PubMed ID: 16862177
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation- and Skp1-independent in vitro ubiquitination of E2F1 by multiple ROC-cullin ligases.
Ohta T; Xiong Y
Cancer Res; 2001 Feb; 61(4):1347-53. PubMed ID: 11245432
[TBL] [Abstract][Full Text] [Related]
31. Structural basis of intersubunit recognition in elongin BC-cullin 5-SOCS box ubiquitin-protein ligase complexes.
Kim YK; Kwak MJ; Ku B; Suh HY; Joo K; Lee J; Jung JU; Oh BH
Acta Crystallogr D Biol Crystallogr; 2013 Aug; 69(Pt 8):1587-97. PubMed ID: 23897481
[TBL] [Abstract][Full Text] [Related]
32. Cdc53 is a scaffold protein for multiple Cdc34/Skp1/F-box proteincomplexes that regulate cell division and methionine biosynthesis in yeast.
Patton EE; Willems AR; Sa D; Kuras L; Thomas D; Craig KL; Tyers M
Genes Dev; 1998 Mar; 12(5):692-705. PubMed ID: 9499404
[TBL] [Abstract][Full Text] [Related]
33. The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts.
Wirbelauer C; Sutterlüty H; Blondel M; Gstaiger M; Peter M; Reymond F; Krek W
EMBO J; 2000 Oct; 19(20):5362-75. PubMed ID: 11032804
[TBL] [Abstract][Full Text] [Related]
34. Role of SOCS and VHL Proteins in Neuronal Differentiation and Development.
Kanno H; Matsumoto S; Yoshizumi T; Nakahara K; Kubo A; Murata H; Shuin T; U HS
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835292
[TBL] [Abstract][Full Text] [Related]
35. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2.
Lonergan KM; Iliopoulos O; Ohh M; Kamura T; Conaway RC; Conaway JW; Kaelin WG
Mol Cell Biol; 1998 Feb; 18(2):732-41. PubMed ID: 9447969
[TBL] [Abstract][Full Text] [Related]
36. Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL.hypoxia-inducible transcription factor-1alpha complex.
Miller F; Kentsis A; Osman R; Pan ZQ
J Biol Chem; 2005 Mar; 280(9):7985-96. PubMed ID: 15611064
[TBL] [Abstract][Full Text] [Related]
37. Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products.
Schoenfeld AR; Davidowitz EJ; Burk RD
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8507-12. PubMed ID: 10900011
[TBL] [Abstract][Full Text] [Related]
38. Rapid E2-E3 assembly and disassembly enable processive ubiquitylation of cullin-RING ubiquitin ligase substrates.
Kleiger G; Saha A; Lewis S; Kuhlman B; Deshaies RJ
Cell; 2009 Nov; 139(5):957-68. PubMed ID: 19945379
[TBL] [Abstract][Full Text] [Related]
39. Substrate-mediated regulation of cullin neddylation.
Chew EH; Hagen T
J Biol Chem; 2007 Jun; 282(23):17032-40. PubMed ID: 17439941
[TBL] [Abstract][Full Text] [Related]
40. BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3.
Xu L; Wei Y; Reboul J; Vaglio P; Shin TH; Vidal M; Elledge SJ; Harper JW
Nature; 2003 Sep; 425(6955):316-21. PubMed ID: 13679922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
